Cargando…

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response

Interleukin-9 (IL-9) is a T cell cytokine that is associated with inflammation and allergy, but the expression level of IL-9 in gastric cancer and its clinical significance are less well established. Our study aims to uncover the critical role of IL-9 in the progression of gastric cancer. Here, a to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, H., Li, R., Gu, Y., Fei, Yuchao, Jin, Kaifeng, Chen, Yifan, Cao, Yifan, Liu, Xin, Lv, Kunpeng, Wang, Jieti, Yu, Kuan, Lin, Chao, Liu, Hao, Li, He, He, Hongyong, Zhang, Weijuan, Zhang, Heng, Shen, Zhenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738302/ https://www.ncbi.nlm.nih.gov/pubmed/33354409 http://dx.doi.org/10.1080/2162402X.2020.1856468

Ejemplares similares

Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer
por: Yu, Kuan, et al.
Publicado: (2022)

Intratumoral CXCR5(+)CD8(+)T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer
por: Wang, Jieti, et al.
Publicado: (2021)

Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer
por: Zhang, Puran, et al.
Publicado: (2022)

Identification and validation of an immunogenic subtype of gastric cancer with abundant intratumoural CD103(+)CD8(+) T cells conferring favourable prognosis
por: Li, Ruochen, et al.
Publicado: (2020)

Intratumoral CD103(+)CD4(+) T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients
por: Gu, Yun, et al.
Publicado: (2020)

Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients
por: Jin, Kaifeng, et al.
Publicado: (2021)

Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy
por: Gu, Yun, et al.
Publicado: (2022)

CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients
por: Cao, Yifan, et al.
Publicado: (2016)

Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer
por: Xia, Siyu, et al.
Publicado: (2021)

Tumor-infiltrating podoplanin(+) cells in gastric cancer: clinical outcomes and association with immune contexture
por: Liu, Xin, et al.
Publicado: (2020)

C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer
por: Liu, Xin, et al.
Publicado: (2023)

Chemotherapeutic nanomaterials in tumor boundary delineation: Prospects for effective tumor treatment
por: Akakuru, Ozioma Udochukwu, et al.
Publicado: (2022)

Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer
por: Lv, Kunpeng, et al.
Publicado: (2023)

Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer
por: Xu, Chang, et al.
Publicado: (2022)

Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles
por: Sitthirak, Sirinya, et al.
Publicado: (2022)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection
por: Li, Ruochen, et al.
Publicado: (2016)

SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma
por: Chen, Ya-Ping, et al.
Publicado: (2019)

Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
por: Zhai, Jiaqi, et al.
Publicado: (2023)

Wound infiltration with ropivacaine as an adjuvant to patient controlled analgesia for transforaminal lumbar interbody fusion: a retrospective study
por: Li, Kunpeng, et al.
Publicado: (2020)

A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020)

Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5(+) CD8(+) T cell abundance
por: Huang, Qiuren, et al.
Publicado: (2020)

Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant–Antigen Codelivery
por: Wang, Zhi-Biao, et al.
Publicado: (2020)

Intratumoral TIGIT(+) CD8(+) T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer
por: Liu, Zhaopei, et al.
Publicado: (2020)

Tumor‐infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer
por: Wang, Jie, et al.
Publicado: (2018)

Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy
por: Lin, Chao, et al.
Publicado: (2016)

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM
por: Feng, Songshan, et al.
Publicado: (2022)

Vaccine adjuvants: mechanisms and platforms
por: Zhao, Tingmei, et al.
Publicado: (2023)

Optimization of Management Zone Delineation for Precision Crop Management in an Intensive Farming System
por: Yuan, Yifan, et al.
Publicado: (2022)

Glycoprotein 130 is associated with adverse postoperative clinical outcomes of patients with late-stage non-metastatic gastric cancer
por: Cao, Yifan, et al.
Publicado: (2016)

Neoadjuvant and Adjuvant Chemotherapeutic Strategy of Colorectal Mixed Adeno-Neuroendocrine Carcinomas
por: Michael, Anita, et al.
Publicado: (2021)

Intratumor depletion of CD4(+) cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors
por: Yu, Ping, et al.
Publicado: (2005)

Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment
por: Roussot, Nicolas, et al.
Publicado: (2022)

An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Pentraxin-3 to better delineate necrotizing soft tissue infection: not really!
por: Honore, Patrick M., et al.
Publicado: (2016)

Intratumoral CCR5(+) neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses
por: Xiang, Zhuoyi, et al.
Publicado: (2020)

Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields)
por: Kirson, Eilon D, et al.
Publicado: (2009)

Adjuvant effects of chemotherapeutics and Metformin on MFE-319 endometrial carcinoma cell line
por: Aydemir, Isil, et al.
Publicado: (2020)

Intratumorally CpG immunotherapy with carbon nanotubes inhibits local tumor growth and liver metastasis by suppressing the epithelial–mesenchymal transition of colon cancer cells
por: Jin, Hongyong, et al.
Publicado: (2020)

Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma
por: Zhuge, Lingdun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vrp3e9bh2gm2do2fhe3ngg57tk